0001062993-24-005969.txt : 20240308
0001062993-24-005969.hdr.sgml : 20240308
20240308161219
ACCESSION NUMBER: 0001062993-24-005969
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240306
FILED AS OF DATE: 20240308
DATE AS OF CHANGE: 20240308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Boston Megan
CENTRAL INDEX KEY: 0001808923
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39267
FILM NUMBER: 24734476
MAIL ADDRESS:
STREET 1: LEVEL 14, 114 WILLIAM ST
CITY: MELBOURNE, VIC
STATE: C3
ZIP: 3000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Benitec Biopharma Inc.
CENTRAL INDEX KEY: 0001808898
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3940 TRUST WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 780-0819
MAIL ADDRESS:
STREET 1: 3940 TRUST WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-03-06
0001808898
Benitec Biopharma Inc.
BNTC
0001808923
Boston Megan
C/O BENITEC BIOPHARMA INC.
3940 TRUST WAY
HAYWARD
CA
94545
1
1
0
0
Executive Director
0
Options (right to buy)
5.21
2024-03-06
4
A
0
200004
0
A
2034-03-06
Common Stock
200004
200004
D
The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.
/s/ Megan Boston
2024-03-08